Though it stays uncertain whether or not the kidney stone scenario was immediately attributable to the immediate weight loss, research advise that GLP-1 agonists—The category of drugs retatrutide belongs to—could add to such hazards.Lately, GLP-one receptor agonists have obtained acceptance for their performance in fat reduction/management and